14152-28-4

14152-28-4 structure
14152-28-4 structure

Name prostaglandin A1
Synonyms (13E,15S)-15-Hydroxy-9-oxoprosta-10,13-dien-1-oic acid PGA1
Prostagladin E1
PROSTAGLANDINS A1
prostaglandina(sup1)
(13E,15S)-15-Hydroxy-9-oxoprosta-10,13-dien-1-oic acid, PGA1
13-dien-1-oicacid,15-hydroxy-9-oxo-,(13e,15s)-prosta-1
(13E)-(15S)-15-Hydroxy-9-oxoprosta-10,13-dienoate
PGA1 (Prostaglandin A1)
Alprostadil (Prostaglandin E1) Impurity A
ProstaglandinA1,(13E,15S)-15-Hydroxy-9-oxoprosta-10,13-dien-1-oic acid, PGA1
Prostaglandin A1
Prostaglandin A1 (25 mg)
2-(3-hydroxy-1-octenyl)-5-oxo-3-cyclopentene-1-htanoicaci
MFCD00077858
prostaglandina(sub1)
prostaglandins A1 synthetic
Prostagladin A
Prostaglandin Impurity A
Prostaglandin A
Prostaglandin (Alprostadil) Impurity A
pga(sup1)
C04685
(13E,15S)-15-Hydroxy-9-oxoprosta-10,13-dien-1-oic acid
Prosta-10,13-dien-1-oic acid, 15-hydroxy-9-oxo-, (13E,15S)
PGA1
[13E,15S]-15-HYDROXY 9-OXOPROSTA-10,13-DIEN-1-OIC ACID
(13E,15S)-15-Hydroxy-9-oxoprosta-10,13-dien-1-oic acid,PGA1
prostaglandine(sup1)-217
pga(sub1)
prostaglandina1syntheticcrystalline
9-OXO-15S-HYDROXY-PROSTA-10,13E-DIEN-1-OIC ACID
a.7-[(1R,2S)-2-[(1e,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopent-3-enyl]htanoicacid(prostaglandina1)
Density 1.1±0.1 g/cm3
Boiling Point 510.7±50.0 °C at 760 mmHg
Melting Point 41 - 43ºC
Molecular Formula C20H32O4
Molecular Weight 336.466
Flash Point 276.7±26.6 °C
Exact Mass 336.230072
PSA 74.60000
LogP 3.61
Vapour Pressure 0.0±3.0 mmHg at 25°C
Index of Refraction 1.541
Storage condition −20°C
Water Solubility acetone: 10 mg/mL, clear

CHEMICAL IDENTIFICATION

RTECS NUMBER :
GY5977900
CHEMICAL NAME :
3-Cyclopentene-1-heptanoic acid, 2-(3-hydroxy-1-octenyl)-5-oxo-
CAS REGISTRY NUMBER :
14152-28-4
LAST UPDATED :
198910
DATA ITEMS CITED :
6
MOLECULAR FORMULA :
C20-H32-O4
MOLECULAR WEIGHT :
336.52
WISWESSER LINE NOTATION :
T5V BUTJ D2YQ5 E6VQ

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
12 mg/kg
SEX/DURATION :
male 10 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Paternal Effects - other effects on male
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravaginal
DOSE :
169 ug/kg
SEX/DURATION :
female 17 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravaginal
DOSE :
169 ug/kg
SEX/DURATION :
female 17 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue) Reproductive - Specific Developmental Abnormalities - urogenital system Reproductive - Specific Developmental Abnormalities - other developmental abnormalities
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
10 mg/kg
SEX/DURATION :
female 16 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetal death
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
40 mg/kg
SEX/DURATION :
female 16 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - abortion

MUTATION DATA

TYPE OF TEST :
Mutation test systems - not otherwise specified
TEST SYSTEM :
Human Cells - not otherwise specified
DOSE/DURATION :
2500 ug/L
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year: 43,513,1983
Personal Protective Equipment Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
Hazard Codes Xn
Safety Phrases S22-S24/25
RIDADR NONH for all modes of transport
WGK Germany 3
RTECS GY5977900
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.